A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
Year: 2018
Type: article
Abstract: Longitudinal PET studies in aging and Alzheimer's disease populations rely on accurate and precise measurements of change over time from serial PET scans. Various methods for partial volume correction (PVC) are commonly applied to such studies, but existing comparisons and validations of these PVC methods have focused on cross-sectional measurements. Rate of change measurements inherently have smaller magnitudes than cross-sectional measurements, so levels of noise amplification due to PVC must be smaller, and it is necessary to re-evaluate methods in this context. Here we compare the relative precision in longitudinal measurements from serial amyloid PET scans when using geometric transfer matrix (GTM) PVC versus the traditional two-compartment (Meltzer-style), three-compartment (Müller-Gärtner-style), and no-PVC approaches. We used two independent implementations of standardized uptake value ratio (SUVR) measurement and PVC (one in-house pipeline based on SPM12 and ANTs, and one using FreeSurfer 6.0). For each approach, we also tested longitudinal-specific variants. Overall, we found that measurements using GTM PVC had significantly worse relative precision (unexplained within-subject variability ≈4-8%) than those using two-compartment, three-compartment, or no PVC (≈2-4%). Longitudinally-stabilized approaches did not improve these properties. This data suggests that GTM PVC methods may be less suitable than traditional approaches when measuring within-person change over time in longitudinal amyloid PET.
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-180749
Institution: Mayo Clinic
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Keywords: partial volume correction, amyloid PET
Open Access status: hybrid
Awards: Multimorbidity and Aging: Rochester Epidemiology Project, Alzheimers Disease Patient Registry, G3930010334, Evaluating and Extending Our Hypothetical Model of Alzheimer's Biomarkers, G5484535055, Development, Validation, and Application of an Imaging based CVD Scale, Brain Aging and Alzheimer's Biomarker Classification Using Amyloid PET, tau PET, and Neurodegeneration on MRI: Developing the ATN system, G9000338148, Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkers, Investigating Resistance and Resilience Mechanisms in Alzheimer’s Disease, Mayo Alzheimer's Disease Research Center
OpenAlex ID: W2900550914
